Presentation Information
[Pj-015-6]Protocol for clinical trial of Mexiletine Hydrochloride in Spinal and Bulbar Muscular Atrophy
Shinichiro Yamada1, Shinobu Shimizu2, Yuri Amano2, Yoshimi Wakasugi2, Fumie Kinoshita2, Yoshiyuki Kishimoto1, Takahiro Kawase1, Atsushi Hashizume3, Daisuke Ito1, Ayano Kondoh1, Yu Mori1, Munetaka Yamamoto1, Ichiro Yabe4, Mitsuya Morita5, Satoshi Kuwabara6, Tatsushi Toda7, Seiichi Nagano8, Masahisa Katsuno1,3 (1.Department of Neurology, Nagoya University Graduate School of Medicine, Japan, 2.Department of Advanced Medicine, Nagoya University Hospital, Japan, 3.Department of Clinical Research Education, Nagoya University Graduate School of Medicine, Japan, 4.Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan, 5.Jichi medical university rehabilitation center, Japan, 6.Department of Neurology, Chiba University, Japan, 7.Department of Neurology, The University of Tokyo, Japan, 8.Department of Neurology, Osaka University Graduate School of Medicine, Japan)